LLY is trading at $1199.00, up 6.3% versus the comparison close of $1127.69 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
π’ LLY extends move to 6.3% up
Eli Lilly and Company
Related News
LLY
Sandoz files for generic Mounjaro and Zepbound, challenging Lillyβs weight-loss lead
LLY
π’ LLY up 4.1% today as Eli Lilly's Jaypirca receives positive EU recommendation for CLL
LLY
Eli Lilly offers Zepbound for $50, targeting 20 million Medicare patients
LLY
π’ LLY is trading 2.2% up today after a $1.9B Abbisko deal and China obesity drug optimism
LLY